| Date | Form | Description | Docs | XBRL | Pages |
| 06/19/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 06/14/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 06/14/13 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 06/14/13 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
16 | |
| 06/11/13 | UPLOAD | SEC-generated letter |
|
1 | |
| 05/28/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
6 | |
| 05/22/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/21/13 | UPLOAD | SEC-generated letter |
|
3 | |
| 05/21/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...